Literature DB >> 26906479

Ventricular-subcutaneous shunt for the treatment of experimental hydrocephalus in young rats: technical note.

Marcelo Volpon Santos1,2, Camila Araujo Bernardino Garcia3, Evelise Oliveira Jardini3, Thais Helena Romeiro3, Luiza da Silva Lopes3, Hélio Rubens Machado4,3, Ricardo Santos de Oliveira4,3.   

Abstract

BACKGROUND: Hydrocephalus is a complex disease that affects cerebrospinal fluid (CSF) dynamics and is very common in children. To this date, CSF shunting is still the standard treatment for childhood hydrocephalus, but, nevertheless, the effects of such an operation on the developing brain are widely unknown. To help overcome this, experimental models of CSF shunts are surely very useful tools.
OBJECTIVE: The objective of this study was to describe a feasible and reliable technique of an adapted ventricular-subcutaneous shunt for the treatment of kaolin-induced hydrocephalus in young rats.
METHODS: We developed a ventricular-subcutaneous shunt (VSCS) technique which was used in 31 Wistar young rats with kaolin-induced hydrocephalus. Hydrocephalus was induced at 7 days of age, and shunt implantation was performed 7 days later. Our technique used a 0.7-mm gauge polypropylene catheter tunneled to a subcutaneous pocket created over the animal's back and inserted into the right lateral ventricle. All animals were sacrificed 14 days after shunt insertion.
RESULTS: Twenty-four rats survived and remained well until the study was ended. No major complications were seen. Their weight gain went back to normal. They all underwent ambulatory behavioral testing prior and after VSCS, which showed improvement in their motor skills. We have also obtained magnetic resonance (MR) scans of 16 pups confirming reduction of ventricular size after shunting and indicating effective treatment. Histopathological analysis of brain samples before and after shunting showed reversion of ependymal and corpus callosum disruption, as well as fewer reactive astrocytes in shunted animals.
CONCLUSIONS: An experimental CSF shunt technique was devised. Excessive CSF of hydrocephalic rats is diverted into the subcutaneous space where it can be resorbed. This technique has a low complication rate and is effective. It might be applied to various types of experimental studies involving induction and treatment of hydrocephalus.

Entities:  

Keywords:  CSF shunting; Cerebrospinal fluid; Experimental hydrocephalus; Kaolin-induced hydrocephalus

Mesh:

Substances:

Year:  2016        PMID: 26906479     DOI: 10.1007/s00381-016-3042-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  21 in total

Review 1.  Cerebrospinal fluid shunt technology.

Authors:  J M Drake; J R Kestle; S Tuli
Journal:  Clin Neurosurg       Date:  2000

2.  Pre- and postshunting magnetization transfer ratios are in accordance with neurological and behavioral changes in hydrocephalic immature rats.

Authors:  Carlos Henrique Rocha Catalão; Diego Augusto Leme Correa; Camila Araújo Bernardino Garcia; Antonio Carlos dos Santos; Carlos Ernesto Garrido Salmon; Maria José Alves Rocha; Luiza da Silva Lopes
Journal:  Dev Neurosci       Date:  2014-10-18       Impact factor: 2.984

3.  A new experimental model of obstructive hydrocephalus in the rat: the micro-balloon technique.

Authors:  D S Kim; S Oi; M Hidaka; O Sato; J U Choi
Journal:  Childs Nerv Syst       Date:  1999-05       Impact factor: 1.475

4.  Progressive ventricular enlargement in the absence of high ventricular pressure in an experimental neonatal rat model.

Authors:  T Erhan Cosan; Alp I Guner; Nevbahar Akcar; Kubilay Uzuner; Esref Tel
Journal:  Childs Nerv Syst       Date:  2002-01-23       Impact factor: 1.475

5.  Changes in brain glutamine synthetase activity in congenital hydrocephalic rats (LEW-HYR) after ventriculoperitoneal shunt.

Authors:  Y Yamada; H Ito; Y Watanabe
Journal:  Neurol Med Chir (Tokyo)       Date:  1997-09       Impact factor: 1.742

6.  Neuronal damage in hydrocephalus and its restoration by shunt insertion in experimental hydrocephalus: a study involving the neurofilament-immunostaining method.

Authors:  Yuichi Aoyama; Yoshimasa Kinoshita; Akira Yokota; Tetsuo Hamada
Journal:  J Neurosurg       Date:  2006-05       Impact factor: 5.115

7.  A novel combined model of intracerebral and intraventricular hemorrhage using autologous blood-injection in rats.

Authors:  I Marinkovic; D Strbian; O S Mattila; U Abo-Ramadan; T Tatlisumak
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

8.  At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?

Authors:  H J Romijn; M A Hofman; A Gramsbergen
Journal:  Early Hum Dev       Date:  1991-07       Impact factor: 2.079

9.  0.1T magnetic resonance image in the study of experimental hydrocephalus in rats. Accuracy of the method in the measurements of the ventricular size.

Authors:  Samuel Caputo de Castro; Hélio Rubens Machado; Carlos Henrique Rocha Catalão; Betina Aisengart de Siqueira; Ana Leda Bertoncini Simões; João-José Lachat; Luiza da Silva Lopes
Journal:  Acta Cir Bras       Date:  2012-11       Impact factor: 1.388

10.  Characterization of juvenile and young adult mice following induction of hydrocephalus with kaolin.

Authors:  Luiza da Silva Lopes; Ili Slobodian; Marc R Del Bigio
Journal:  Exp Neurol       Date:  2009-05-19       Impact factor: 5.330

View more
  2 in total

1.  Evaluation of the effects of quercetin on brain lesions secondary to experimental hydrocephalus in rats.

Authors:  G B Sampaio; S C Da Silva; T H Romeiro; P D S Beggiora; H R Machado; L D S Lopes
Journal:  Childs Nerv Syst       Date:  2019-05-27       Impact factor: 1.475

2.  Impaired neural differentiation and glymphatic CSF flow in the Ccdc39 rat model of neonatal hydrocephalus: genetic interaction with L1cam.

Authors:  A Scott Emmert; Eri Iwasawa; Crystal Shula; Preston Schultz; Diana Lindquist; R Scott Dunn; Elizabeth M Fugate; Yueh-Chiang Hu; Francesco T Mangano; June Goto
Journal:  Dis Model Mech       Date:  2019-11-21       Impact factor: 5.758

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.